| Course | PA 514 Comprehensive Clinical Module Infectious Disease |
|---|---|
| Week | 7 |
| Paper type | Stop date justification |
| Length | About 660 words, 5 pages |
| Format | APA 7 student paper |
| School | Chamberlain University |
| Program | Master of Physician Assistant Studies (MPAS) |
| Updated | October 2026 |
Free sample paper for PA 514 Week 7
Stop Date Justification: Fourteen Days of Ceftriaxone Counted From Thursday Night, April 9, a Last Dose on Wednesday, April 22, and the Events That Would and Would Not Move It
Student Name
Chamberlain University
PA 514: Comprehensive Clinical Module Infectious Disease
Instructor Name
Month Day, Year
Stop Date Justification: Fourteen Days of Ceftriaxone Counted From Thursday Night, April 9, a Last Dose on Wednesday, April 22, and the Events That Would and Would Not Move It
Which Day Is Day One
Day one is Thursday, April 9, when the first dose of ceftriaxone was given at 11:30 p.m. Three other days could have been chosen. The day symptoms began, April 7, precedes treatment and does not measure therapy. The day the organism was named, April 11, reflects laboratory timing, not treatment. The day of the first negative blood culture, April 11, is sometimes used when bacteremia persists on therapy. Here, ceftriaxone was active against the isolate from the first dose, and the first follow-up culture, taken about 31 hours later, was negative, so there is no evidence of persistent bacteremia to justify counting from a later day.
The Number, With Its Source
Fourteen days. A randomized trial found that 7 days of covering therapy was not inferior to 14 days for uncomplicated gram-negative bacteremia in hospitalized patients who were stable before day 7 (Yahav et al., 2019). That result does not transfer cleanly to R.A. In the trial, about two thirds of infections came from the urinary tract, while R.A.'s came from the gut. R.A. is immunosuppressed by methotrexate, and nontyphoidal Salmonella bacteremia in adults over 50 carries a recognized risk of seeding blood vessels, which is why the IDSA guideline names older adults with atherosclerosis and people with immunosuppression as groups at higher risk of invasive infection (Shane et al., 2017). The 14-day arm is therefore the figure used, applied to a gut-source bacteremia in an immunosuppressed host rather than borrowed from a urinary population.
A Date, Not a Duration
Fourteen daily doses beginning Thursday, April 9, end with the fourteenth dose on Wednesday, April 22. The stop date written on the chart and the outpatient infusion order is Thursday, April 23: no dose on that day.
What Would Move It
The date would move later if any of these occurred: a follow-up blood culture growing Salmonella, which would restart the count from the first negative culture; imaging showing infection of the aorta or another vessel, which would call for a much longer course; or a joint, bone or abscess infection. It would not move earlier, because the reasons for choosing 14 rather than 7 days remain.
What Does Not Restart the Count
Several events do not restart day one. Moving ceftriaxone from the hospital to an outpatient infusion center on April 13 is a change of place, not of therapy. A single temperature of 37.9 C on April 14 with negative cultures is not a new infection. Restarting methotrexate, which rheumatology plans after the course ends, has no effect on the count. A missed dose, if one occurs, extends the end date by one day but does not restart it.
Checks Before the Last Dose
Two checks are planned before April 22. A clinic visit on April 20 will confirm that R.A. has been free of fever and diarrhea and will review a complete blood count and creatinine, since methotrexate has been held and the kidney injury has resolved. If either check raises a new concern, the stop date is reviewed then, not on the day of the last dose. R.A. has been told the date and what to watch for after stopping, including a return of fever, which would need blood cultures before any further antibiotic.
The Record
The stop date, the start event and the reason for 14 days are written in the discharge summary and on the infusion order, so the outpatient team does not have to reconstruct them.
References
Shane, A. L., Mody, R. K., Crump, J. A., Tarr, P. I., Steiner, T. S., Kotloff, K., Langley, J. M., Wanke, C., Warren, C. A., Cheng, A. C., Cantey, J., & Pickering, L. K. (2017). 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clinical Infectious Diseases, 65(12), e45-e80. https://doi.org/10.1093/cid/cix669
Yahav, D., Franceschini, E., Koppel, F., Turjeman, A., Babich, T., Bitterman, R., Neuberger, A., Ghanem-Zoubi, N., Santoro, A., Eliakim-Raz, N., Pertzov, B., Steinmetz, T., Stern, A., Dickstein, Y., Maroun, E., Zayyad, H., Bishara, J., Alon, D., Edel, Y., . . . Paul, M. (2019). Seven versus 14 days of antibiotic therapy for uncomplicated gram-negative bacteremia: A noninferiority randomized controlled trial. Clinical Infectious Diseases, 69(7), 1091-1098. https://doi.org/10.1093/cid/ciy1054
Reading the PA 514 Week 7 instructions
The seventh week asks you to set and defend the end of antibiotic therapy. Choose day one and explain why, comparing it with other start points such as symptom onset, identification or the first negative culture. State the total length and support it with a cited study or guideline, then explain whether that evidence applies to your patient, considering source, host factors and complications. Convert the length into a calendar date for the last dose and a date when no dose is given. List the findings that would extend therapy and say whether any would shorten it. Separately, list events that do not change the count, such as a move to outpatient infusion. Plan checks before the final dose. Finally, record where the stop date is written so the next team can see it.
How the PA 514 Week 7 example is put together
The paper fixes day one at the first ceftriaxone dose at 11:30 p.m. on April 9 and explains why onset, identification day and the first negative culture were each rejected, noting the negative repeat culture after about 31 hours. Fourteen days is defended against the Yahav trial, which found seven days noninferior in uncomplicated gram-negative bacteremia, by pointing out that most trial infections were urinary and this patient is immunosuppressed and over 50, a group the IDSA guideline flags for invasive salmonellosis. The length becomes a fourteenth dose on April 22 and a written stop on April 23. Separate sections list what would extend therapy and what would not reset it, from a site-of-care change to a missed dose. Checks on April 20 and the location of the documented stop date close the paper.
Where the points sit in the PA 514 Week 7 rubric
Points for this justification gather around three judgments: the choice of day one, the length and the date. Faculty deduct most for a duration given without a source, or with a source whose population does not match the patient and is not discussed. A day one chosen without comparison to alternatives also costs significant marks. Credit rises when the stop date is written as a calendar date on a named order rather than as a number of days. The sections on what extends therapy and what does not reset it are marked for clinical accuracy and specificity. Planned checks earn a smaller share when they include tests and a decision point before the last dose. APA citation of the trial and guideline, with full reference entries, completes the expected format.
PA 514 Week 7 help from the desk
Students commonly lose marks here by quoting a course length without saying when it starts. If you share your case, the organism and the treatment so far, the custom sample will choose a day one, compare it with the other options and give a cited length checked against your patient's host factors. The duration is turned into a dated last dose and a stop line for the order your course uses. It lists what would extend or leave unchanged the plan in your situation, including site-of-care changes and missed doses. Where your instructor names a particular guideline, the reasoning follows that source. Dates and doses should be rechecked against your own case before you borrow any of the argument.
Get a PA-514 Week 7 example written to your instructions
Send the Week 7 instructions and the case as your section wrote it, and a custom example is returned inside 24 to 48 hours with the start event, the citation and the calendar arithmetic all set out. The first one is free. Name the guidance your section expects to see cited and that is the one the example uses.
More PA 514 papers and MPAS samples
- PA 514 Week 1: Exposure-First Discussion Post
- PA 514 Week 2: Exposure History Timeline
- PA 514 Week 3: Incubation Window Analysis
- PA 514 Week 4: Empiric Coverage Rationale
- PA 514 Week 5: Culture Narrowing Memo
- PA 514 Week 6: Antibiogram Reading Exercise
- PA 514 Week 8: Reportable Condition Brief
- PA 512 Week 7: Tumor Marker Monitoring Brief
- PA 510 Week 7: Biopsy Site Justification
- PA 505 Week 7: Risk Formulation Note
- PA 504 Week 7: Note Revision Exercise
PA 514 Week 7 questions, answered
The guidance gives a range rather than a single length.
Most of it does, and the range is where the assignment lives. The finished example states the span, picks a point inside it, and gives the feature of this case that justified the choice, which is exactly the sentence a rubric row tends to be written for. Taking the top of a range by default and saying nothing about it is the common deduction.
Does the piece have to give a calendar date?
In most sections yes, and it is worth checking, because a number of days is easy to write and impossible to act on without the start event beside it. Where a section asks only for a duration, the start event still has to appear, since that is the half of the answer a reader cannot reconstruct alone.
Is admitting the date might change a weakness?
The opposite, provided the conditions are named. A date offered as unconditional is the version that reads as unexamined, because nothing in a case like this is ever that settled. What loses points is the open ending dressed up as flexibility: a piece listing everything that might matter and never committing to a day at all.
Where can I find a free PA 514 Week 7 sample paper?
This page carries the full PA 514 Week 7 stop date justification, fourteen days of ceftriaxone ending with a last dose on April 22 and the events that would move it.
Why does the PA 514 Week 7 sample choose fourteen days instead of seven?
The seven day trial mostly studied urinary infections, while this patient has gut-source Salmonella bacteremia, is over 50 and takes methotrexate, a group at higher risk of invasive spread.